Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically determined recurrent fevers.

M Delpech1, G Grateau

  • 1Génétique et Physiopathologie des Maladies Inflammatoires, Institut National de la Santé et de la Recherche Médicale (INSERM) EMI 00-05, Faculté de Médecine Cochin Port-Royal, 24 rue du fg St Jacques, 75014, Paris, France. delpech@cohin.inserm.fr

Current Opinion in Immunology
|September 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

French protocol for the diagnosis and management of familial Mediterranean fever.

La Revue de medecine interne·2023
Same author

French practical guidelines for the diagnosis and management of AA amyloidosis.

La Revue de medecine interne·2023
Same author

Poor performance of albumin or protein-adjusted plasma calcium to diagnose dyscalcemia in hospitalized patients: A confirmatory study in a general internal medicine department.

La Revue de medecine interne·2021
Same author

Tattooing and autoinflammatory diseases: a study among 197 French patients from the JIR cohort.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Is neutrophilic dermatosis a manifestation of familial Mediterranean fever?

Scandinavian journal of rheumatology·2021
Same author

[Periodic fever syndrome associated with mutations in the TNF type 1 receptor gene: A differential diagnosis of familial Mediterranean fever that should not be overlooked in patients of Mediterranean origin].

La Revue de medecine interne·2020
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Molecular diagnosis is crucial for recurrent fevers like familial Mediterranean fever (FMF). MEFV gene mutations and SAA1 alleles influence FMF severity and amyloidosis risk, with human mutations showing ancestral traits.

Area of Science:

  • Genetics
  • Molecular Biology
  • Immunology

Background:

  • Genetic mutations in MEFV are linked to familial Mediterranean fever (FMF) severity and renal amyloidosis.
  • The serum amyloid-associated protein (SAA)1 alpha/alpha allele acts as a modifier for amyloidosis in FMF patients.
  • TNF-receptor-associated periodic syndrome (TRAPS) appears more common following the identification of its causative gene.

Purpose of the Study:

  • To explore the genetic underpinnings of recurrent fevers, focusing on MEFV mutations in FMF.
  • To investigate the role of SAA1 alleles in modifying amyloidosis risk in FMF.
  • To assess the prevalence and genetic characteristics of TNF-receptor-associated periodic syndrome (TRAPS).

Main Methods:

  • Analysis of MEFV gene mutations in patients with familial Mediterranean fever.

Related Experiment Videos

  • Genotyping for the serum amyloid-associated protein (SAA)1 alpha/alpha allele.
  • Comparative genetic studies across species to understand mutation origins.
  • Review of clinical data for TNF-receptor-associated periodic syndrome cases.

    • Main Results:

    • MEFV mutations correlate with FMF severity and amyloidosis risk.
    • The SAA1 alpha/alpha genotype is identified as a significant modifying factor for amyloidosis.
    • Human MEFV mutations reflect ancestral states, with key domains absent in rodent models.
    • New mutations in the TRAPS-associated gene suggest increased frequency and incomplete penetrance in some cases.

    Conclusions:

    • Molecular diagnostics are essential for managing genetically determined recurrent fevers.
    • Understanding genetic factors like MEFV mutations and SAA1 alleles improves FMF patient outcomes.
    • Further research into TRAPS genetics is warranted due to observed incomplete penetrance.